Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract - Is there evidence for discordant biology?

Journal of Urology

Volumn 191, Issue 4, 2014, Pages 926-931

  Krabbe, Laura Maria ^a,b   Lotan, Yair ^a   Bagrodia, Aditya ^a   Gayed, Bishoy A ^a   Darwish, Oussama M ^a   Youssef, Ramy F ^a   Bolenz, Christian ^c   Sagalowsky, Arthur I ^a   Raj, Ganesh V ^a   Shariat, Shahrokh F ^d   Kapur, Payal ^a   Margulis, Vitaly ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

biological markers; carcinoma; transitional cell; urinary bladder neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN E; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SYSTEMIC THERAPY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT SURGERY; CANCER CHEMOTHERAPY; CANCER GRADING; CELL PROLIFERATION; RECURRENT DISEASE;

BIOLOGICAL MARKERS; CARCINOMA; TRANSITIONAL CELL; URINARY BLADDER NEOPLASMS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PROSPECTIVE STUDIES; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 84898475489     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.09.031     Document Type: Article

References (20)

1. J.J. Munoz, and L.M. Ellison Upper tract urothelial neoplasms: incidence and survival during the last 2 decades J Urol 164 2000 1523
2. J.W. Catto, D.R. Yates, and I. Rehman et al. Behavior of urothelial carcinoma with respect to anatomical location J Urol 177 2007 1715
3. S. Moussa, F.A. Yafi, and A. El-Hakim et al. Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison Urol Int 84 2010 50
4. M. Rink, B. Ehdaie, and E.K. Cha et al. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery Eur Urol 62 2012 677
5. Y. Lotan, A. Bagrodia, and N. Passoni et al. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy Eur Urol 64 2013 465
6. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual, 7th ed. New York: Springer-Verlag 2010.
7. S.F. Shariat, P.I. Karakiewicz, and R. Ashfaq et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy Cancer 112 2008 315
8. T. Takahashi, T. Habuchi, and Y. Kakehi et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract Cancer Res 58 1998 5835
9. T.D. Jones, M. Wang, and J.N. Eble et al. Molecular evidence supporting field effect in urothelial carcinogenesis Clin Cancer Res 11 2005 6512
10. F. Rabbani, M. Perrotti, and P. Russo et al. Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance J Clin Oncol 19 2001 94
11. T.F. Chromecki, K. Bensalah, and M. Remzi et al. Prognostic factors for upper urinary tract urothelial carcinoma Nat Rev Urol 8 2011 440
12. V. Margulis, Y. Lotan, and P.I. Karakiewicz et al. Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer J Natl Cancer Inst 101 2009 114
13. B.H. Bochner, M.W. Kattan, and K.C. Vora Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer J Clin Oncol 24 2006 3967
14. D.A. Green, M. Rink, and E. Xylinas et al. Urothelial carcinoma of the bladder and the upper tract: disparate twins J Urol 189 2013 1214
15. S.S. Taneja Re: Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery J Urol 188 2012 756
16. E. Xylinas, M. Rink, and V. Margulis et al. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy BJU Int 112 2013 453
17. G.V. Raj, S. Karavadia, and B. Schlomer et al. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer Cancer 117 2011 276
18. P.I. Liang, Y.H. Wang, and T.F. Wu et al. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder J Clin Pathol 66 2013 573
19. G. Gakis, C. Schwentner, and T. Todenhofer et al. Current status of molecular markers for prognostication and outcome in invasive bladder cancer BJU Int 110 2012 233
20. C. Jeldres, M. Sun, and G. Lughezzani et al. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma Cancer 116 2010 3774